Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 15, 2016 - Issue 2
Submit an article Journal homepage
247
Views
11
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

A Safety Evaluation of Cangrelor in Patients Undergoing PCI

Francesco FranchiDepartment of Medicine, Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, FL, USA
,
Fabiana RolliniDepartment of Medicine, Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, FL, USA
,
Yongwhi ParkDepartment of Medicine, Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, FL, USA;Division of Cardiology, Gyeongsang National University Hospital, Jinju, Korea
&
Dominick J. AngiolilloDepartment of Medicine, Division of Cardiology, University of Florida College of Medicine-Jacksonville, Jacksonville, FL, USACorrespondence[email protected]
Pages 275-285 | Received 03 Nov 2015, Accepted 14 Dec 2015, Published online: 09 Jan 2016

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Piera Capranzano & Dominick J. Angiolillo. (2021) Tackling the gap in platelet inhibition with oral antiplatelet agents in high-risk patients undergoing percutaneous coronary intervention. Expert Review of Cardiovascular Therapy 19:6, pages 519-535.
Read now
Rocco P. Milluzzo, Gabriele A. Franchina, Davide Capodanno & Dominick J. Angiolillo. (2020) Selatogrel, a novel P2Y12 inhibitor: a review of the pharmacology and clinical development. Expert Opinion on Investigational Drugs 29:6, pages 537-546.
Read now
Sergio Buccheri, Davide Capodanno, Stefan James & Dominick J. Angiolillo. (2019) Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigms. Expert Opinion on Drug Safety 18:12, pages 1171-1189.
Read now

Articles from other publishers (8)

Giulia Alagna, Paolo Mazzone, Marco Contarini & Giuseppe Andò. (2023) Dual Antiplatelet Therapy with Parenteral P2Y12 Inhibitors: Rationale, Evidence, and Future Directions. Journal of Cardiovascular Development and Disease 10:4, pages 163.
Crossref
Leonardo De Luca, Philippe Gabriel Steg, Deepak L. Bhatt, Davide Capodanno & Dominick J. Angiolillo. (2021) Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives. Journal of the American Heart Association 10:13.
Crossref
Craig Basman, Afnan Tariq, Yuvrajsinh J. Parmar, Deepak Asti, Neil L. Coplan, Varinder P. Singh & Carl D. Reimers. (2018) Antiplatelet and anticoagulation therapy during percutaneous coronary interventions: A review for the interventionalist. Journal of Interventional Cardiology 31:5, pages 693-704.
Crossref
Dominick J. AngiolilloFabiana RolliniRobert F. StoreyDeepak L. BhattStefan JamesDavid J. SchneiderDirk SibbingDerek Y.F. SoDietmar TrenkDimitrios AlexopoulosPaul A. GurbelWillibald HochholzerLeonardo De LucaLaurent BonelloDaniel AradiThomas CuissetUdaya S. TantryTracy Y. WangMarco ValgimigliRon WaksmanRoxana MehranGilles MontalescotFrancesco FranchiMatthew J. Price. (2017) International Expert Consensus on Switching Platelet P2Y 12 Receptor–Inhibiting Therapies . Circulation 136:20, pages 1955-1975.
Crossref
Francesco Franchi, Fabiana Rollini & Dominick J. Angiolillo. (2017) Antithrombotic therapy for patients with STEMI undergoing primary PCI. Nature Reviews Cardiology 14:6, pages 361-379.
Crossref
Fabiana Rollini, Francesco Franchi & Dominick J. Angiolillo. (2017) Switching P2Y12 Receptor Inhibiting Therapies. Interventional Cardiology Clinics 6:1, pages 67-89.
Crossref
Davide Capodanno & Dominick J. Angiolillo. (2017) Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention. Interventional Cardiology Clinics 6:1, pages 13-24.
Crossref
Tushar Kotecha & Roby D Rakhit. (2016) Acute coronary syndromes. Clinical Medicine 16:Suppl 6, pages s43-s48.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.